Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R, Travert F.

N Engl J Med. 2008 Jun 12;358(24):2560-72. doi: 10.1056/NEJMoa0802987. Epub 2008 Jun 6.

2.

Effect of the anti-anginal agent, perhexiline, on neutrophil, valvular and vascular superoxide formation.

Kennedy JA, Beck-Oldach K, McFadden-Lewis K, Murphy GA, Wong YW, Zhang Y, Horowitz JD.

Eur J Pharmacol. 2006 Feb 15;531(1-3):13-9. Epub 2006 Jan 17.

PMID:
16413015
3.

Dissociation between metabolic and efficiency effects of perhexiline in normoxic rat myocardium.

Unger SA, Kennedy JA, McFadden-Lewis K, Minerds K, Murphy GA, Horowitz JD.

J Cardiovasc Pharmacol. 2005 Dec;46(6):849-55.

PMID:
16306812

Supplemental Content

Loading ...
Support Center